Jackson Square Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Jackson Square Capital's GILD Position: Q3 2026 in Review
Jackson Square Capital opened a new position in Gilead Sciences (GILD) in Q3 2026: 2,069 shares worth $308K. The stake represents 0.05% of the portfolio and ranks #124 among its holdings. This is a return to the name: Jackson Square Capital previously reported a position in GILD as recently as Q1 2026.
Jackson Square Capital first reported a position in GILD in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.62M in Q1 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Jackson Square Capital held 2,069 shares of Gilead Sciences worth $308K as of Q3 2026.
- Gilead Sciences was a new Jackson Square Capital position in Q3 2026.
- Gilead Sciences made up 0.05% of Jackson Square Capital's portfolio in Q3 2026, its #124 holding.
- Jackson Square Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 16 quarters since.
- Jackson Square Capital's Gilead Sciences position peaked at $2.62M in Q1 2026.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.